These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31152759)

  • 1. UL23, UL30, and UL5 characterization of HSV1 clinical strains isolated from hematology department patients.
    Labrunie T; Ducastelle S; Domenech C; Ader F; Morfin F; Frobert E
    Antiviral Res; 2019 Aug; 168():114-120. PubMed ID: 31152759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.
    Burrel S; Deback C; Agut H; Boutolleau D
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4833-42. PubMed ID: 20733037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel UL23 and UL30 substitutions in HSV1 and HSV2 viruses related to polymorphism or drug resistance.
    Giorgi J; Simon B; Destras G; Semanas Q; Ginevra C; Boyer T; Regue H; Billaud G; Ducastelle S; Ader F; Morfin F; Josset L; Frobert E
    Antiviral Res; 2023 Aug; 216():105672. PubMed ID: 37453453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
    Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
    Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of mutations in DNA polymerase and thymidine kinase genes of herpes simplex virus clinical isolates resistant to antiherpetic drugs].
    Korovina AN; Gus'kova AA; Skoblov MIu; Andronova VL; Galegov GA; Kochetkov SN; Kukhanova MK; Skoblov IuS
    Mol Biol (Mosk); 2010; 44(3):488-96. PubMed ID: 20608173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
    Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High conservation of herpes simplex virus UL5/UL52 helicase-primase complex in the era of new antiviral therapies.
    Collot M; Rouard C; Brunet C; Agut H; Boutolleau D; Burrel S
    Antiviral Res; 2016 Apr; 128():1-6. PubMed ID: 26826441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase-primase inhibitors in their mode of interaction with the antiviral target.
    Biswas S; Kleymann G; Swift M; Tiley LS; Lyall J; Aguirre-Hernández J; Field HJ
    J Antimicrob Chemother; 2008 May; 61(5):1044-7. PubMed ID: 18299638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance.
    Schmidt S; Bohn-Wippert K; Schlattmann P; Zell R; Sauerbrei A
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4938-45. PubMed ID: 26055375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase-primase inhibitors, variously affect virus growth rate and pathogenicity.
    Biswas S; Tiley LS; Zimmermann H; Birkmann A; Field HJ
    Antiviral Res; 2008 Oct; 80(1):81-5. PubMed ID: 18539344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus resistance to antiviral drugs.
    Morfin F; Thouvenot D
    J Clin Virol; 2003 Jan; 26(1):29-37. PubMed ID: 12589832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.
    Burrel S; Aime C; Hermet L; Ait-Arkoub Z; Agut H; Boutolleau D
    Antiviral Res; 2013 Nov; 100(2):365-72. PubMed ID: 24075863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir).
    Chono K; Katsumata K; Kontani T; Shiraki K; Suzuki H
    Biochem Pharmacol; 2012 Aug; 84(4):459-67. PubMed ID: 22687623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
    Sauerbrei A; Deinhardt S; Zell R; Wutzler P
    Antiviral Res; 2010 Jun; 86(3):246-52. PubMed ID: 20211650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France.
    Frobert E; Burrel S; Ducastelle-Lepretre S; Billaud G; Ader F; Casalegno JS; Nave V; Boutolleau D; Michallet M; Lina B; Morfin F
    Antiviral Res; 2014 Nov; 111():36-41. PubMed ID: 25218782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UL52 primase interactions in the herpes simplex virus 1 helicase-primase are affected by antiviral compounds and mutations causing drug resistance.
    Muylaert I; Zhao Z; Elias P
    J Biol Chem; 2014 Nov; 289(47):32583-92. PubMed ID: 25278021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of therapy using a helicase-primase inhibitor (HPI) in mice infected with deliberate mixtures of wild-type HSV-1 and an HPI-resistant UL5 mutant.
    Sukla S; Biswas S; Birkmann A; Lischka P; Ruebsamen-Schaeff H; Zimmermann H; Field HJ
    Antiviral Res; 2010 Jul; 87(1):67-73. PubMed ID: 20420855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase-primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture.
    Biswas S; Jennens L; Field HJ
    Arch Virol; 2007; 152(8):1489-500. PubMed ID: 17404685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
    Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
    Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Helicase-Primase Inhibitor Amenamevir-Resistant Herpes Simplex Virus.
    Sato Y; Suenaga T; Kobayashi M; Miyazaki N; Suzuki T; Ishioka K; Suzutani T
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0049421. PubMed ID: 34228537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.